Reciprocal Regulation of MAGED2 and HIF-1α Augments Their Expression under Hypoxia: Role of cAMP and PKA Type II

Cells. 2022 Oct 29;11(21):3424. doi: 10.3390/cells11213424.

Abstract

Hypoxia stabilizes the transcription factor HIF-1α, which promotes the transcription of many genes essential to adapt to reduced oxygen levels. Besides proline hydroxylation, expression of HIF-1α is also regulated by a range of other posttranslational modifications including phosphorylation by cAMP-dependent protein kinase A (PKA), which stabilizes HIF-1α. We recently demonstrated that MAGED2 is required for cAMP generation under hypoxia and proposed that this regulation may explain the transient nature of antenatal Bartter syndrome (aBS) due to MAGED2 mutations. Consequently, we sought to determine whether hypoxic induction of HIF-1α requires also MAGED2. In HEK293 and HeLa cells, MAGED2 knock-down impaired maximal induction of HIF-1α under physical hypoxia as evidenced by time-course experiments, which showed a signification reduction of HIF-1α upon MAGED2 depletion. Similarly, using cobalt chloride to induce HIF-1α, MAGED2 depletion impaired its appropriate induction. Given the known effect of the cAMP/PKA pathway on the hypoxic induction of HIF-1α, we sought to rescue impaired HIF-1α induction with isoproterenol and forskolin acting upstream and downstream of Gαs, respectively. Importantly, while forskolin induced HIF-1α above control levels in MAGED2-depleted cells, isoproterenol had no effect. To further delineate which PKA subtype is involved, we analyzed the effect of two PKA inhibitors and identified that PKA type II regulates HIF-1α. Interestingly, MAGED2 mRNA and protein were also increased under hypoxia by a cAMP mimetic. Moreover, MAGED2 protein expression also required HIF-1α. Thus, our data provide evidence for reciprocal regulation of MAGED2 and HIF-1α under hypoxia, revealing therefore a new regulatory mechanism that may further explain the transient nature of aBS caused by MAGED2 mutations.

Keywords: Bartter; GalphaS; HIF-1α; MAGED2; PKA type II; hypoxia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing* / metabolism
  • Antigens, Neoplasm
  • Colforsin / pharmacology
  • Cyclic AMP-Dependent Protein Kinases* / metabolism
  • Female
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Hypoxia* / genetics
  • Hypoxia* / metabolism
  • Hypoxia-Inducible Factor 1, alpha Subunit* / metabolism
  • Isoproterenol
  • Pregnancy

Substances

  • Adaptor Proteins, Signal Transducing
  • Antigens, Neoplasm
  • Colforsin
  • Cyclic AMP-Dependent Protein Kinases
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Isoproterenol
  • MAGED2 protein, human

Grants and funding

This work was supported by a grant from the German Research Foundation (DFG) Ko1855/4-1 and Behring Röntgen Foundation, grant 67-0061 (MK, Martin Kömhoff). Open Access funding provided by the Open Acess Publication Fund of Philipps-Universität Marburg with support of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).